The future of TKIs in pediatric medicine looks promising, with ongoing research aimed at improving their efficacy and reducing side effects. Newer-generation TKIs and combination therapies are being explored to overcome resistance and improve outcomes. Personalized medicine approaches, which tailor treatment based on the individual genetic profile of the patient, also hold great potential.
